EuractivZelenskyy says has had talks on Ukraine with US envoys ucofeurope / December 25, 2025 “There are good ideas that can work toward a shared outcome and the lasting peace,” he said on social media
EuractivRussian bombers carry out ‘scheduled’ flight north of Scandinavia ucofeurope / December 25, 2025 “At certain stages of the route, long-range bombers were escorted by fighter jets of foreign countries,” Russia’s defence ministry said
EuractivHard to hit pause: Excessive gaming lands on the EU’s radar ucofeurope / December 25, 2025 EU lawmakers are eyeing controls on ‘loot boxes’ and other addictive features in video games via the upcoming Digital Fairness Act
EuractivSugar tax proposal sparks debate in Germany ucofeurope / December 24, 2025 The opposition criticised the plan for targeting consumers rather than imposing stricter rules on manufacturers
EuractivZelenskyy outlines revised Ukraine peace plan freezing front line with Russia ucofeurope / December 24, 2025 Zelenskyy said Ukraine would hold presidential elections only after an agreement is signed
EuractivGermany and France risk missing FCAS fighter jet’s New Year deadline ucofeurope / December 24, 2025 A German government spokesperson said on Friday that there was still ample time before the end of the year to find a solution for FCAS
EuractivUS visa bans spark EU backlash over digital rules ucofeurope / December 24, 2025 Breton was described by the State Department as the “mastermind” of the European Union’s Digital Services Act
EuractivSpain promotes festive pork dishes amid swine fever comeback ucofeurope / December 24, 2025 Efforts to protect the pig sector from reputational damage come as the origin of the outbreak remains unresolved
EuractivWho killed the Green Deal? A Christmas murder mystery ucofeurope / December 24, 2025 Euractiv brings you a fresh twist on an old classic
EuractivPoland’s judicial ‘speed bumps’ create legal uncertainty for EU pharma reforms [Advocacy Lab] ucofeurope / December 23, 2025 Poland’s procedural delays effectively nullify pharmaceutical patent rights, creating a ‘launch at risk’ haven, a new legal opinion warns